- Home
- ANEB vs GROW Comparison
ANEB vs GROW Comparison
Compare ANEB & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- GROW
- Stock Information
- Founded
- ANEB 2020
- GROW 1968
- Country
- ANEB United States
- GROW United States
- Employees
- ANEB N/A
- GROW N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- GROW Investment Managers
- Sector
- ANEB Health Care
- GROW Finance
- Exchange
- ANEB Nasdaq
- GROW Nasdaq
- Market Cap
- ANEB 111.8M
- GROW 32.2M
- IPO Year
- ANEB 2021
- GROW N/A
- Fundamental
- Price
- ANEB $2.56
- GROW $2.57
- Analyst Decision
- ANEB Buy
- GROW
- Analyst Count
- ANEB 2
- GROW 0
- Target Price
- ANEB $8.00
- GROW N/A
- AVG Volume (30 Days)
- ANEB 29.2K
- GROW 55.3K
- Earning Date
- ANEB 11-12-2025
- GROW 11-06-2025
- Dividend Yield
- ANEB N/A
- GROW 3.50%
- EPS Growth
- ANEB N/A
- GROW N/A
- EPS
- ANEB N/A
- GROW N/A
- Revenue
- ANEB N/A
- GROW $8,452,000.00
- Revenue This Year
- ANEB N/A
- GROW N/A
- Revenue Next Year
- ANEB N/A
- GROW N/A
- P/E Ratio
- ANEB N/A
- GROW N/A
- Revenue Growth
- ANEB N/A
- GROW N/A
- 52 Week Low
- ANEB $0.80
- GROW $2.02
- 52 Week High
- ANEB $3.42
- GROW $2.78
- Technical
- Relative Strength Index (RSI)
- ANEB 56.80
- GROW 48.80
- Support Level
- ANEB $2.30
- GROW $2.55
- Resistance Level
- ANEB $2.74
- GROW $2.72
- Average True Range (ATR)
- ANEB 0.14
- GROW 0.08
- MACD
- ANEB 0.03
- GROW -0.02
- Stochastic Oscillator
- ANEB 65.00
- GROW 11.36
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.